Orthotopic neobladder following radical cystectomy in patients with high perioperative risk and co-morbid medical conditions

被引:24
作者
Parekh, DJ [1 ]
Clark, T [1 ]
O'Connor, J [1 ]
Jung, C [1 ]
Chang, SS [1 ]
Cookson, M [1 ]
Smith, JA [1 ]
机构
[1] Vanderbilt Univ, Dept Urol Surg, Nashville, TN 37232 USA
关键词
cystectomy; comorbidity; bladder neoplasms;
D O I
10.1016/S0022-5347(05)64166-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: A significant number of patients requiring radical cystectomy for bladder cancer have substantial co-morbidity. Nonetheless, these patients often prefer orthotopic neobladder reconstruction to avoid an abdominal stoma. We performed a retrospective study to determine perioperative morbidity in this group of patients. Materials and Methods: We used the American Society of Anesthesiologists physical status classification to assign perioperative risk. Of 250 patients undergoing orthotopic neobladder reconstruction after radical cystectomy during a 5-year period we identified 84 with an American Society of Anesthesiologists score of 3 or greater. Charts were available for review for all patients and none was lost to followup. Results: Median operative time (calculated from anesthesia ready time to completion of surgery and application of a dressing) was 256 minutes. In 14 patients (16.6%) transfusion of a median of 2 units of allogeneic blood was required. A total of 79 patients (94%) were transferred directly from. the recovery room to the general urology floor without a need for postoperative cardiac monitoring. Median hospital stay was 7 days. One patient (1.1%) died on postoperative day 9 of a presumed pulmonary embolus after having been discharged home on postoperative day 6. Minor. complication occurred in 16 patients (19%). Only 1 patient required a return to the operating room for endoscopic removal of a retained stent fragment. Conclusions: In experienced hands radical cystectomy and orthotopic neobladder can be offered to patients with co-morbid conditions. Expeditious performance of the surgical procedure, minimization of blood loss, restricting the surgical incision to an infraumbilical location, and avoidance of intraoperative complications all contribute to decreasing morbidity and mortality. Although orthotopic reconstruction is more complex than performance of an ileal conduit, there is no apparent increase in perioperative morbidity or mortality. Therefore, orthotopic reconstruction can be offered to patients who want to avoid an abdominal stoma even in the face of significant co-morbid conditions.
引用
收藏
页码:2454 / 2456
页数:3
相关论文
共 43 条
[31]   The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour [J].
Solsona, E ;
Iborra, I ;
Rubio, J ;
Casanova, J ;
Almenar, S .
BJU INTERNATIONAL, 2004, 94 (09) :1258-1262
[32]   Totally intracorporeal 3D laparoscopic orthotopic neobladder reconstruction following radical cystectomy for infiltrative bladder tumors: the experience of modified Studer and modified Y-shaped ileal reconstruction techniques [J].
Rusu, Cristian Bogdan ;
Bujoreanu, Cristina Eliza ;
Irimie, Alexandru ;
Achimas-Cadariu, Patriciu ;
Vlad, Catalin ;
Kubelac, Paul ;
Hardo, Vlad Vasile ;
Maghiar, Teodor Traian ;
Maris, Cristian Vasile ;
Idris, Yousif ;
Petrut, Bogdan .
JOURNAL OF BUON, 2020, 25 (01) :286-294
[33]   Diagnosis, risk factors, and outcome of urethral recurrences following radical cystectomy for bladder cancer in 729 male patients [J].
Huguet, Jorge ;
Monllau, Vanesa ;
Sabate, Sergi ;
Rodriquez-Faba, Oscar ;
Algaba, Ferran ;
Palou, Juan ;
Villavicencio, Humberto .
EUROPEAN UROLOGY, 2008, 53 (04) :785-793
[34]   Survival of Patients with Chronic Kidney Disease Treated with Radical Cystectomy and Risk Factors of Glomerular Filtration Rate Loss Following Radical Cystectomy: Two Systematic Reviews and Meta-analyses of Interplay Between Radical Cystectomy and Renal Function [J].
Motlagh, Reza Sari ;
Ghoreifi, Alireza ;
Yanagisawa, Takafumi ;
Kawada, Tatsushi ;
Kikic, Zeljko ;
Gill, Inderbir ;
Daneshmand, Siamak ;
Djaladat, Hooman ;
Shariat, Shahrokh F. .
EUROPEAN UROLOGY FOCUS, 2024, 10 (01) :169-181
[35]   The impact of perioperative risk factors on long-term survival after radical cystectomy: a prospective, high-volume cohort study [J].
Pyrgidis, Nikolaos ;
Schulz, Gerald B. ;
Volz, Yannic ;
Ebner, Benedikt ;
Rodler, Severin ;
Westhofen, Thilo ;
Eismann, Lennert ;
Marcon, Julian ;
Stief, Christian G. ;
Jokisch, Friedrich .
WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
[36]   Internal double-J stent was associated with a lower incidence of ureteroileal anastomosis stricture than external ureteral catheter for patients undergoing radical cystectomy and orthotopic neobladder: A systematic review and meta-analysis [J].
Yang, Yubo ;
Bai, Yunjin ;
Wang, Xiaoming ;
Tang, Yin ;
Han, Ping ;
Wei, Xin .
INTERNATIONAL JOURNAL OF SURGERY, 2019, 72 :80-84
[37]   Radikale Zystektomie und Harnableitung beim älteren Patienten mit erhöhter Komorbidität Radical cystectomy and urinary diversion in elderly patients with comorbid medical conditions [J].
J. E. Gschwend ;
R. E. Hautmann ;
B. G. Volkmer .
Der Urologe, Ausgabe A, 2004, 43 :930-934
[38]   Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: The concept of lymph node density [J].
Stein, JP ;
Cai, J ;
Groshen, S ;
Skinner, DG .
JOURNAL OF UROLOGY, 2003, 170 (01) :35-41
[39]   There is a place for radical cystectomy and urinary diversion, including orthotopic bladder substitution, in patients aged 75 and older: Results of a retrospective observational analysis from a high-volume center [J].
Wuethrich, Patrick Y. ;
Vidal, Alvaro ;
Burkhard, Fiona C. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (02) :58.e19-58.e27
[40]   Prescription pattern of non-steroidal anti-inflammatory drugs (NSAIDs) among community patients with musculoskeletal and co-morbid conditions: A cross-sectional study from an Iraqi province [J].
Al-Taie, Anmar ;
Hussein, Ali N. ;
Albasry, Zahraa .
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2021, 20 (01) :203-210